Founded FreeStride Therapeutics, a virtual company that develops FDA-approved drugs for veterinary use, focusing on thoroughbred horses with later extension to other companion animals. Recruited SMT, including a CEO for FreeStride. Co-manage all operations with CEO (currently a part-time effort). Oversee all start-up operations, including budget development, business plan development, capital acquisition, etc. Currently overseeing and coordinating FreeStrideâs first animal clinical studies (thoroughbred race horses).
Alturus Biomedicine is a development company that both starts Life Science companies and helps those in existence grow. Our current focus is in regenerative medicine. Alturus has worked with a broad range of companies from start up to major biopharmaceutical corporations both in the US and internationally. Areas of interest include: Regenerative Medicine. Alturus Biomedicine has extensive experience in the scientific basis of regenerative medicine and its commercialization. Regenerative Medicine is broadly defined as a multidisciplinary approach to restoring, or providing new tissues for damaged ones. Perhaps the most important medical area of the 21st Century, Regenerative Medicine offers the potential to cure rather than treat most diseases . Stem Cells. Alturus has expertise with both the academic research and commercial development of stem cells as therapies. Stem Cells have been utilized for over 35 years in the form of bone marrow transplantation. Recent advances demonstrate that such cells can replace many adult tissues and over 2000 clinical trials are underway to test them. Drug Discovery & Development. Alturus has expertise in developing human cell-based platforms for both drug discovery and toxicity testing. Our development experience covers the areas of: drug synthesis, lead identification/ optimization, in vivo and vitro efficacy, ADME, toxicity and preclinical animal studies. Clinical Trials. Alturus has designed and overseen clinical trials in both human and veterinary medicine. Expertise includes site selection, CRO selection, trial design and FDA interactions (IND application and compliance). Economic Development. Alturus has worked with regional and local governments to develop public-private partnerships. These were undertaken to co-develop high-tech job creation and develop regional strengths in translational medicine.
Founded company to develop a portfolio of bone therapy programs. In-licensed and developed to clinical-phase a highly effective molecule for Rheumatoid Arthritis. Built companyâs business development and licensing function, including strategic direction, team formation and execution of a partnering initiative. Led senior scientific/commercial team to introduce Velcura programs to potential partners Oversee all start-up and emerging phase operations, including budget management, business plan development, capital acquisition, etc.
Over 25 years of volunteer experience with the Society a $300 Million per year non-profit organization; six years as member of Medical & Scientific Board, 18 years as National Board member (overlapping terms) and six years as a member of the Society's Executive Committee. Multiple committees and oversight responsibilities there involved CEO selection, corporate oversight, fundraising, strategic planning, and legal affairs.
Research in the areas of cell and molecular biology and received more than $15 million in funding rom the National Institutes of Health. As a professor, developed the technology for bone cell analysis and for forming human bone outside the body, ultimately generating 15 patents as the primary inventor. Member (4 years )the Hematology scientific review committee at the National Institutes of Health (2001 - 2005) and nave reviewed grant applications for the American Cancer Society, the Leukemia & Lymphoma Society, and other national organizations. Past reviewer for Science, Nature, Nature Biotechnology, and 23 other scientific publications. He is often invited to speak at national scientific conferences and is the author of over 70 publications. Completed a post-doctoral fellowship at the Sloan Kettering Memorial Cancer Center and a sabbatical in one of the Howard Hughes Medical Institute laboratories.
MSc, PhD
Concentration: Human Physiology
BSc,
Concentration: Biology
This BrandYourself profile is automatically optimized to show up high in Google